Claims for Patent: 8,741,956

Summary for Patent: 8,741,956

Title:	Treatment of pain with topical diclofenac
Abstract:	The field involves compositions useful for pain relief, including diclofenac solution and gel formulations, in particular methods of use thereof, articles of manufacture and kits that provide novel preclinical, clinical and other information to users.
Inventor(s):	Singh; Jagat (Scarborough, CA), Shainhouse; Joseph Zev (North York, CA), Galer; Bradley S. (West Chester, PA), King-Smith; Robert Dominic (San Diego, CA), Grierson; Lisa Marie (Richmond Hill, CA), Burian; Maria (Stolberg, DE), Wilkin; Jonathan (Columbus, OH), Kisak; Edward (San Diego, CA), Newsam; John M. (La Jolla, CA)
Assignee:	Nuvo Research Inc. (Mississauga, CA)
Application Number:	13/668,061
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,741,956
Patent Claims:	1. A method for treating a patient having pain, said method comprising: administering a therapeutically effective amount of an oral NSAID along with applying a topical diclofenac preparation to a knee of said patient to treat osteoarthritis, wherein said topical diclofenac preparation comprises a therapeutically effective amount of a diclofenac salt and 40-50% w/w dimethyl sulfoxide; and informing the patient to conduct periodic laboratory evaluations, wherein the therapeutically effective amount of oral NSAID is the amount required to achieve a therapeutic effect in the absence of applying a topical diclofenac preparation. 2. The method according to claim 1, further comprising: conducting periodic laboratory evaluations. 3. The method according to claim 1, wherein the informing step is by written instruction. 4. The method according to claim 1, wherein the written instruction is a product insert. 5. The method according to claim 1, wherein said diclofenac preparation comprises about 45.5% w/w dimethyl sulfoxide. 6. The method according to claim 1, wherein said diclofenac preparation further comprises ethanol, propylene glycol, glycerine, and water. 7. The method according to claim 1, wherein said therapeutically effective amount of diclofenac salt comprises a pharmaceutically acceptable salt of diclofenac selected from a sodium salt, a potassium salt, a diethylamine salt, or an epolamine salt. 8. The method according to claim 1, wherein said therapeutically effective amount of diclofenac is 1.5% w/w diclofenac sodium. 9. The method according to claim 1, wherein said oral NSAID is a member selected from the group consisting of a COX-2 selective NSAID, diclofenac, tenoxicam, meloxicam, celecoxib, diflunisal, etodolac, fenoprofen, flurbiprofen, ibuprofen, indomethacin, ketoprofen, ketorolac, mefenamic acid, nabumetone, naproxen, oxaprozin, piroxicam, sulindac, and tolmetin. 10. A method for treating a patient with pain, said method comprising: administering a therapeutically effective amount of an oral NSAID along with applying a topical diclofenac preparation to a knee of said patient to treat osteoarthritis, wherein said topical diclofenac preparation comprises a therapeutically effective amount of a diclofenac salt and 40-50% w/w dimethyl sulfoxide; informing the patient to conduct periodic laboratory evaluations; and conducting periodic laboratory evaluations. 11. The method according to claim 10, wherein the informing step is by written instruction. 12. The method according to claim 11, wherein the written instruction is a product insert. 13. The method according to claim 10, wherein said diclofenac preparation comprises about 45.5% w/w dimethyl sulfoxide. 14. The method according to claim 10, wherein said diclofenac preparation further comprises ethanol, propylene glycol, glycerine, and water. 15. The method according to claim 10, wherein said therapeutically effective amount of diclofenac salt comprises a pharmaceutically acceptable salt of diclofenac selected from a sodium salt, a potassium salt, a diethylamine salt, or an epolamine salt. 16. The method according to claim 10, wherein said therapeutically effective amount of diclofenac is 1.5% w/w diclofenac sodium. 17. The method according to claim 10, wherein said oral NSAID is a member selected from the group consisting of a COX-2 selective NSAID, diclofenac, tenoxicam, meloxicam, celecoxib, diflunisal, etodolac, fenoprofen, flurbiprofen, ibuprofen, indomethacin, ketoprofen, ketorolac, mefenamic acid, nabumetone, naproxen, oxaprozin, piroxicam, sulindac, and tolmetin. 18. A method for treating a patient having pain, said method comprising: (a) administering a therapeutically effective amount of an oral NSAID along with applying a topical diclofenac preparation to a knee of said patient to treat osteoarthritis, wherein said topical diclofenac preparation comprises a therapeutically effective amount of a diclofenac salt and 40-50% w/w dimethyl sulfoxide; and (b) conducting periodic laboratory evaluations, wherein administering, applying, and conducting are performed in accordance with written instructions. 19. The method of claim 18, wherein the written instruction is a product insert. 20. The method according to claim 18, wherein said diclofenac preparation comprises about 45.5% w/w dimethyl sulfoxide. 21. The method according to claim 18, wherein said diclofenac preparation further comprises ethanol, propylene glycol, glycerine, and water. 22. The method according to claim 18, wherein said therapeutically effective amount of diclofenac salt comprises a pharmaceutically acceptable salt of diclofenac selected from a sodium salt, a potassium salt, a diethylamine salt, or an epolamine salt. 23. The method according to claim 18, wherein said therapeutically effective amount of diclofenac is 1.5% w/w diclofenac sodium.